Literature DB >> 15531259

Do environmental pollutants influence the onset of respiratory syncytial virus epidemics or disease severity?

Jayesh M Bhatt1, Mark L Everard.   

Abstract

The trigger for annual epidemics of respiratory syncytial virus (RSV) infections and the factors contributing to the disappearance of RSV infections in late winter remain obscure. Similarly, there is no adequate explanation for the higher morbidity and admission rates in industrialised as compared with rural areas. It has been suggested that a variety of environmental factors such as temperature, daylight and humidity may influence the onset and waning of the epidemics. However, the few studies assessing these variables fail to support such a link. In many tropical countries the annual epidemic occurs in the summer or autumn, arguing against temperature having a direct influence. A number of studies have suggested that indoor pollutants, including cigarette smoke, are associated with an increased likelihood of being admitted to hospital with severe lower respiratory tract disease. One study exploring the potential role of outdoor pollutants on the pattern of RSV related illness in infancy was unable to identify a clear link between a variety of pollutants and the timing of the epidemic. Nitric oxide levels were higher in winter than during the summer and much higher winter peaks of NO were observe in industrialised areas as compared with urban and rural areas. Whether this or other environmental pollutants contribute to the higher incidence of severe disease in industrialised areas is unclear. Further work is required to explore the possible influence of NO and other environmental pollutants on both the timing and severity of epidemics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531259     DOI: 10.1016/j.prrv.2004.07.003

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  9 in total

1.  Environmental Cadmium Enhances Lung Injury by Respiratory Syncytial Virus Infection.

Authors:  Xin Hu; Ki-Hye Kim; Youri Lee; Jolyn Fernandes; M Ryan Smith; Yu-Jin Jung; Michael Orr; Sang-Moo Kang; Dean P Jones; Young-Mi Go
Journal:  Am J Pathol       Date:  2019-05-18       Impact factor: 4.307

Review 2.  The role of the respiratory syncytial virus in airway syndromes in childhood.

Authors:  Mark L Everard
Journal:  Curr Allergy Asthma Rep       Date:  2006-03       Impact factor: 4.806

3.  Persistent of respiratory syncytial virus in human dendritic cells and influence of nitric oxide.

Authors:  L Hobson; M L Everard
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

4.  The influence of diurnal temperature range on the incidence of respiratory syncytial virus in Japan.

Authors:  D Onozuka
Journal:  Epidemiol Infect       Date:  2014-06-24       Impact factor: 4.434

5.  Investigation of occurrence patterns of respiratory syncytial virus A and B in infected-patients from Cheonan, Korea.

Authors:  Ga-Yeon Kim; Insoo Rheem; You Hyun Joung; Jae Kyung Kim
Journal:  Respir Res       Date:  2020-07-18

6.  Meteorological drivers of respiratory syncytial virus infections in Singapore.

Authors:  Sheikh Taslim Ali; Clarence C Tam; Benjamin J Cowling; Kee Thai Yeo; Chee Fu Yung
Journal:  Sci Rep       Date:  2020-11-24       Impact factor: 4.379

Review 7.  Respiratory syncytial virus persistence in macrophages alters the profile of cellular gene expression.

Authors:  Evelyn Rivera-Toledo; Beatríz Gómez
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

8.  A Preliminary Assessment of the Role of Ambient Nitric Oxide Exposure in Hospitalization with Respiratory Syncytial Virus Bronchiolitis.

Authors:  Nuredin I Mohammed; Mark L Everard; Jon G Ayres; Nicola J Barker; Ian J Litchfield
Journal:  Int J Environ Res Public Health       Date:  2016-06-09       Impact factor: 3.390

9.  Infective respiratory syncytial virus is present in human cord blood samples and most prevalent during winter months.

Authors:  Angela Mary Fonceca; Abha Chopra; Avram Levy; Paul Stanton Noakes; Matthew Wee-Peng Poh; Natasha Leanne Bear; Susan Prescott; Mark Lloyd Everard
Journal:  PLoS One       Date:  2017-04-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.